PTC Therapeutics Inc (NASDAQ:PTCT)

53.88
Delayed Data
As of Jul 28
 +0.50 / +0.94%
Today’s Change
26.02
Today|||52-Week Range
78.72
+4.08%
Year-to-Date

Today’s Trading

Previous close53.38
Today’s open53.54
Day’s range-- - --
Volume752,913
Average volume (3 months)688,266
Market cap$1.8B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-59.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book5.88

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc+0.53+3.43%
FOLDAmicus Therapeutics ...+0.69+4.37%
TTPHTetraphase Pharmaceu...-0.37-0.76%
MNKDMannkind Corp+0.05+1.05%
Data as of 07/28/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers